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Membrane Attachment Slows Down Prion Protein Aggregation
PAGE 994
Toxic conformations of proteins are the cause of many severe diseases in humans. The prion protein (PrP) is special among
these proteins because it is an infectious agent that can convert native PrP into its toxic isoform. This process most likely
takes place in the natural environment of PrP, the outer leaflet of the cell membrane. To elucidate this process, Olschewski
et al. have established two semisynthetic strategies to obtain recombinant PrP equipped with a C-terminal GPI anchor
mimic. These strategies allowed the study of membrane-attached PrP and led to the findings that membrane attachment
slows down formation of PrP aggregates. An important step towards elucidating prion conversion and turn-over was
achieved by transfer of semisynthetic PrP into the plasma membrane of cells.
Regulation of Neural Stem Cell Differentiation
PAGE 1019
Neural stem cells (NSCs) hold great promise for repair of the nervous system following
injury or disease. Small molecules that specifically enhance the production of neurons
from NSCs are highly sought after. Saxe et al. found that in cell-based phenotypic
screening with primary cultured murine NSCs, a serine metabolite, phosphoserine,
promotes the differentiation and survival of neurons produced from NSCs. Target
identification studies demonstrated a role for metabotropic glutamate receptor 4 in
NSC biology and revealed novel receptor coupling to the mTor signaling pathway.
Phosphoserine was also found to be an efficient means to enhance neuron production
from human ES cells.
Probing G Protein Signaling
PAGE 1007
There exists a lack of small moleculemodulators for G proteins due to their extremely tight affinity towards GDP andGTP. In
this issue, Vincent et al. report small molecules developed for the highly specific inhibition or activation of the engineered G
protein. The rational design preserved binding of the natural substrates to theGprotein, and themutationswere functionally
silent in a cellular context. This novel tool can be used for isolating specific G protein effectors as the authors demonstrate
with the identification of Nol1 as a putative novel effector of H-Ras. Finally, the generalization of this system was confirmed
by applying it to Rap1B, suggesting that this method will be applicable to other G proteins.
Harvesting the Power of Heparan Biosynthetic Enzymes
PAGE 986
Heparan sulfate (HS) is a highly sulfated polysaccharide with a wide
range of biological activities. Heparin, an analog of HS, is a commonly
used anticoagulant drug. Chemical synthesis of HSwith specific sulfation
patterns is difficult, especially for those molecules larger than a hexasac-
charide. Furthermore, these hexasaccharides may not fully represent
the functions of the polysaccharide. As reported in this issue, Chen
et al. utilized an array of heparan biosynthetic enzymes to synthesize a
small library with eight unique polysaccharides. The authors discovered
novel structures with anticoagulant activity. In general, this enzymatic
approach could be used to develop any polysaccharide-based therapeu-
tic reagents.
Reaching the Target: Reversibly Modified Hydrophobic Prodrugs
PAGE 1065
Monahan et al. have developed the use of reversibly modified hydrophobic prodrugs for first-pass targeting of liver tumors
in loco-regional therapy. In this study, authors demonstrate that hydrophobicity dramatically enhances tumor cell targeting
in vitro and in vivo. Incorporating rapid lability to the hydrophobic moiety protects nontargeted tissues from exposure to the
highly active agent. Utilizing this methodology, authors demonstrate that a cell-impermeable compound can be converted
into an active therapeutic, thereby potentially leading to the development of therapeutics with low systemic toxicity. This
approach is particularly applicable to first-pass treatment strategies involving liver tumors or ovarian cancer.Chemistry & Biology 14, September 2007 ª2007 Elsevier Ltd All rights reserved ix
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Cytochrome P450 enzymes, a large and diverse protein family in mammals, play key
roles in the metabolism of endogenous signaling molecules, xenobiotics, and drugs.
As Wright and Cravatt report, a broad-spectrum, mechanism-based P450 inhibitor,
2-ethynylnaphthalene, was converted into an activity-based chemical proteomics
probe by derivatization with a versatile click chemistry handle that enabled the selective
tagging, detection, enrichment, and identification of P450 enzymes in any biological
system. The activity-based probe proved capable of monitoring both drug induction
and inhibition of P450 enzymes in vivo. This chemical proteomic strategy offers a versa-
tile method to monitor P450 activities and small molecule interactions and should
facilitate the functional characterization of this large and diverse enzyme class.
Evolving Enzymes with Retained Activity in Organic Cosolvents
PAGE 1052
Mimicking the Darwinist algorithm of natural selection, directed molecular evolution allows the tailoring of enzymes to be
more robust, stable, and in general exhibit many improved features, through several rounds of random mutagenesis and
DNA recombination. Due to their high versatility, fungal laccases are considered among themost promising green catalysts
of this century. In their current work, Zumarraga et al. tailored a fungal laccase that tolerates high concentrations of organic
cosolvents, a property that is not required in this enzyme’s natural environment, in five cycles of directed evolution. The
expression of this enzyme in Saccharomyces cerevisiae allowed authors to use this organism as a DNA-recombination
toolbox to generate diversity.
Dye-Triggered Aggregation Reveals PKA Dynamics in Living Cells
PAGE 1031
The tetracysteine sequence YRECCPGCCMWR fused to the N-terminus of green fluores-
cent protein (GFP) self-aggregates upon biarsenical labeling in living cells or in vitro. Such
dye-triggered aggregates form temperature-dependent morphologies and are dispersed
by photobleaching. Fusion of the biarsenical aggregating GFP (BA-GFP) to the regulatory
or catalytic subunit of PKA traps intact holoenzyme in compact fluorescent puncta upon
biarsenical labeling. Surprisingly, Martin et al. show that elevated cAMP does not allow
RIa and Ca to diffuse far apart unless the pseudosubstrate inhibitor PKI or locally concen-
trated substrate is coexpressed. Overall, effective separation of type I PKA is substrate
dependent, whereas type II PKA dissociation relies on autophosphorylation.
Type-IV Glycopeptide Side-Chain Cyclization
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The P450-type monooxygenases StaF, StaG, StaH, and StaJ of the A47934 producer S. toyocaensis catalyze crosslinking
and form the linear precursors to a tetracyclic glycopeptide antibiotic scaffold that is the base for antibiotic activity.
Hadatsch et al. used gene inactivation to correlate the position of biaryl- and biarylether-crosslinks in the peptide backbone
and the catalyzing oxygenase. Functional assignment and deduction of the biosynthetic sequence for oxygenase steps
was achieved only when the combination of the mass spectrometric analysis for both the gene inactivation mutants and
the wild-type cultures was employed. This study sheds new light on our understanding of glycopeptide biosyntheses
and reveals features unique to type-IV glycopeptide antibiotics.x Chemistry & Biology 14, September 2007 ª2007 Elsevier Ltd All rights reserved
